SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-10-015316
Filing Date
2010-03-19
Accepted
2010-03-19 09:17:50
Documents
8
Effectiveness Date
2010-03-19

Document Format Files

Seq Description Document Type Size
1 DEFA14A a10-1457_3defa14a.htm DEFA14A 41605
2 GRAPHIC g14573bci001.gif GRAPHIC 50777
3 GRAPHIC g14573bci002.gif GRAPHIC 79721
4 GRAPHIC g14573bci003.gif GRAPHIC 17745
5 GRAPHIC g14573bei001.gif GRAPHIC 50412
6 GRAPHIC g14573bei002.gif GRAPHIC 82967
7 GRAPHIC g14573bei003.gif GRAPHIC 19557
8 GRAPHIC g14573bei004.gif GRAPHIC 4145
  Complete submission text file 0001104659-10-015316.txt   464736
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19700 | Film No.: 10693046
SIC: 2834 Pharmaceutical Preparations